Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3127.5
(0.03%)
INR 3127.5
(0.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 106.05 Billion INR | 13.36% |
| 2022 | 94.63 Billion INR | 12.41% |
| 2021 | 84.18 Billion INR | 6.75% |
| 2020 | 78.86 Billion INR | 1.37% |
| 2019 | 77.8 Billion INR | 4.26% |
| 2018 | 74.61 Billion INR | 28.1% |
| 2017 | 58.24 Billion INR | 2.69% |
| 2016 | 56.72 Billion INR | -13.0% |
| 2015 | 65.19 Billion INR | 42.38% |
| 2014 | 45.78 Billion INR | 13.55% |
| 2013 | 40.32 Billion INR | 32.27% |
| 2012 | 30.48 Billion INR | 17.57% |
| 2011 | 25.92 Billion INR | 22.61% |
| 2010 | 21.14 Billion INR | 15.38% |
| 2009 | 18.32 Billion INR | 12.4% |
| 2008 | 16.3 Billion INR | 20.36% |
| 2007 | 13.54 Billion INR | 4.32% |
| 2006 | 12.98 Billion INR | 34.29% |
| 2005 | 9.67 Billion INR | 76.57% |
| 2004 | 5.47 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 28.59 Billion INR | 4.15% |
| 2024 Q2 | 28.31 Billion INR | 1.05% |
| 2023 Q2 | 26.28 Billion INR | 3.14% |
| 2023 Q3 | 26.91 Billion INR | 2.4% |
| 2023 Q1 | 25.48 Billion INR | 3.93% |
| 2023 FY | 107.28 Billion INR | 13.36% |
| 2023 Q4 | 27.45 Billion INR | 2.01% |
| 2022 Q4 | 24.51 Billion INR | -0.3% |
| 2022 Q3 | 24.59 Billion INR | 8.76% |
| 2022 FY | 94.63 Billion INR | 12.41% |
| 2022 Q1 | 22.92 Billion INR | 8.95% |
| 2022 Q2 | 22.61 Billion INR | -1.35% |
| 2021 FY | 84.18 Billion INR | 6.75% |
| 2021 Q2 | 21.03 Billion INR | -0.8% |
| 2021 Q1 | 21.2 Billion INR | 10.69% |
| 2021 Q3 | 20.92 Billion INR | -0.52% |
| 2021 Q4 | 21.03 Billion INR | 0.56% |
| 2020 Q3 | 19.72 Billion INR | -0.65% |
| 2020 Q4 | 19.15 Billion INR | -2.88% |
| 2020 FY | 78.86 Billion INR | 1.37% |
| 2020 Q2 | 19.85 Billion INR | -1.44% |
| 2020 Q1 | 20.14 Billion INR | 5.33% |
| 2019 Q2 | 19.68 Billion INR | -0.4% |
| 2019 FY | 77.8 Billion INR | 4.26% |
| 2019 Q3 | 19.24 Billion INR | -2.24% |
| 2019 Q1 | 19.76 Billion INR | 8.46% |
| 2019 Q4 | 19.12 Billion INR | -0.62% |
| 2018 Q3 | 19.48 Billion INR | 4.84% |
| 2018 Q2 | 18.58 Billion INR | 1.31% |
| 2018 FY | 74.61 Billion INR | 28.1% |
| 2018 Q4 | 18.21 Billion INR | -6.48% |
| 2018 Q1 | 18.34 Billion INR | 9.17% |
| 2017 Q4 | 16.8 Billion INR | 17.15% |
| 2017 FY | 58.24 Billion INR | 2.69% |
| 2017 Q3 | 14.34 Billion INR | 3.24% |
| 2017 Q2 | 13.89 Billion INR | 3.97% |
| 2017 Q1 | 13.36 Billion INR | -3.26% |
| 2016 Q1 | 15.13 Billion INR | 2.44% |
| 2016 FY | 56.72 Billion INR | -13.0% |
| 2016 Q4 | 13.81 Billion INR | -2.26% |
| 2016 Q3 | 14.13 Billion INR | 0.5% |
| 2016 Q2 | 14.06 Billion INR | -7.07% |
| 2015 Q1 | 18.86 Billion INR | 67.23% |
| 2015 Q3 | 15.18 Billion INR | -8.39% |
| 2015 Q4 | 14.77 Billion INR | -2.7% |
| 2015 FY | 65.19 Billion INR | 42.38% |
| 2015 Q2 | 16.57 Billion INR | -12.14% |
| 2014 Q4 | 11.27 Billion INR | -2.44% |
| 2014 Q2 | 12.03 Billion INR | 10.16% |
| 2014 FY | 45.78 Billion INR | 13.55% |
| 2014 Q1 | 10.92 Billion INR | -9.25% |
| 2014 Q3 | 11.56 Billion INR | -3.91% |
| 2013 Q2 | 9.36 Billion INR | 3.65% |
| 2013 Q4 | 12.03 Billion INR | 21.55% |
| 2013 FY | 40.32 Billion INR | 32.27% |
| 2013 Q3 | 9.9 Billion INR | 5.77% |
| 2013 Q1 | 9.03 Billion INR | 13.28% |
| 2012 Q3 | 7.68 Billion INR | 2.81% |
| 2012 Q2 | 7.47 Billion INR | 1.49% |
| 2012 FY | 30.48 Billion INR | 17.57% |
| 2012 Q1 | 7.36 Billion INR | 12.54% |
| 2012 Q4 | 7.97 Billion INR | 3.79% |
| 2011 Q3 | 6.73 Billion INR | 0.0% |
| 2011 FY | 25.92 Billion INR | 22.61% |
| 2011 Q4 | 6.54 Billion INR | -2.89% |
| 2010 FY | 21.14 Billion INR | 15.38% |
| 2009 FY | 18.32 Billion INR | 12.4% |
| 2008 FY | 16.3 Billion INR | 20.36% |
| 2007 FY | 13.54 Billion INR | 4.32% |
| 2006 FY | 12.98 Billion INR | 34.29% |
| 2005 FY | 9.67 Billion INR | 76.57% |
| 2004 FY | 5.47 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 78.132% |
| NATCO Pharma Limited | 40.02 Billion INR | -165.003% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -908.74% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -3990.907% |
| Achyut Healthcare Limited | 61.36 Million INR | -172714.124% |
| Ajanta Pharma Limited | 42.08 Billion INR | -151.988% |
| Alkem Laboratories Limited | 126.67 Billion INR | 16.279% |
| Alpa Laboratories Limited | 1.08 Billion INR | -9653.106% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -73.515% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -718.617% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 63.053% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -2140.184% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -1276.891% |
| Brooks Laboratories Limited | 794.86 Million INR | -13242.496% |
| Divi's Laboratories Limited | 78.45 Billion INR | -35.187% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 62.01% |
| Eris Lifesciences Limited | 20.09 Billion INR | -427.858% |
| FDC Limited | 19.42 Billion INR | -445.843% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 10.223% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -364.496% |
| Granules India Limited | 45.06 Billion INR | -135.343% |
| Gufic Biosciences Limited | 8.06 Billion INR | -1214.724% |
| Hester Biosciences Limited | 3.04 Billion INR | -3382.374% |
| Indoco Remedies Limited | 17.89 Billion INR | -492.664% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -727.967% |
| Ipca Laboratories Limited | 76.22 Billion INR | -39.135% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -4981.614% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -20933.547% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -10064.787% |
| Laurus Labs Limited | 50.01 Billion INR | -112.032% |
| Lupin Limited | 200.1 Billion INR | 47.002% |
| Mankind Pharma Limited | 103.34 Billion INR | -2.619% |
| Medicamen Biotech Limited | 1.79 Billion INR | -5814.703% |
| Medico Remedies Limited | 1.44 Billion INR | -7218.092% |
| Megasoft Limited | 373.95 Million INR | -28260.329% |
| Piramal Pharma Limited | 81.71 Billion INR | -29.791% |
| RPG Life Sciences Limited | 5.82 Billion INR | -1722.082% |
| Sigachi Industries Limited | 3.98 Billion INR | -2558.295% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -13938.504% |
| Unichem Laboratories Limited | 16.57 Billion INR | -539.877% |
| Wanbury Limited | 5.75 Billion INR | -1742.341% |
| Windlas Biotech Limited | 6.3 Billion INR | -1580.851% |
| ZIM Laboratories Limited | 3.67 Billion INR | -2786.425% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 44.245% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -821.202% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -2417.726% |
| Bal Pharma Limited | 3.39 Billion INR | -3026.42% |
| Strides Pharma Science Limited | 40.51 Billion INR | -161.79% |
| Venus Remedies Limited | 5.91 Billion INR | -1693.125% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -484.159% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -529.744% |
| Shilpa Medicare Limited | 11.51 Billion INR | -820.928% |
| Aarti Drugs Limited | 25.28 Billion INR | -319.423% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -400.502% |
| Suven Life Sciences Limited | 116.92 Million INR | -90599.741% |
| Ind-Swift Limited | 5.02 Billion INR | -2010.667% |
| Valiant Laboratories Limited | 1.82 Billion INR | -5725.329% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | -204.388% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -756.389% |
| Themis Medicare Limited | 3.81 Billion INR | -2678.03% |
| Hikal Limited | 17.84 Billion INR | -494.275% |
| Sequent Scientific Limited | 13.69 Billion INR | -674.271% |
| Novartis India Limited | 3.35 Billion INR | -3065.139% |
| Wockhardt Limited | 27.89 Billion INR | -280.259% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -58.222% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -26390.197% |
| Neuland Laboratories Limited | 15.58 Billion INR | -580.454% |
| Morepen Laboratories Limited | 17.01 Billion INR | -523.153% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -6770.025% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -2777.26% |